z-logo
Premium
Maternal manifestation of B allantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma
Author(s) -
Takahashi Hironori,
Matsubara Shigeki,
Kuwata Tomoyuki,
Ohkuchi Akihide,
Mukoda Yukiko,
Saito Koyomi,
Usui Rie,
Suzuki Mitsuaki
Publication year - 2014
Publication title -
journal of obstetrics and gynaecology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1341-8076
DOI - 10.1111/jog.12286
Subject(s) - medicine , fetus , edema , lung , etiology , pulmonary edema , pregnancy , pathology , obstetrics , genetics , biology
Abstract Various fetal or placental disorders cause B allantyne's (mirror) syndrome. For the first time, we report a maternal manifestation of B allantyne's syndrome occurring concomitantly with the development of fetal congenital mesoblastic nephroma ( CMN ). In a pregnant woman with a CMN fetus, lung edema, hypertension, hyperthyroidism, and high serum human chorionic gonadotrophin level occurred, all of which characterize maternal manifestation of B allantyne's syndrome. The fetus and placenta were devoid of ‘edema’, lacking ‘triple edema’, and thus this condition was not diagnosed as B allantyne's syndrome; however, we considered this condition as the maternal manifestation of B allantyne's syndrome. We performed emergent cesarean section at 28 weeks. Delivery acutely ameliorated maternal symptoms. Tumor was resected and was confirmed as CMN . Maternal manifestations of B allantyne's syndrome, such as lung edema and hypertension, can occur in a mother with fetal CMN even without fetal and/or placental edema. The clinical course of this patient may suggest an etiology of B allantyne's syndrome.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom